<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00230984</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 01 05</org_study_id>
    <nct_id>NCT00230984</nct_id>
  </id_info>
  <brief_title>IRAD2 : Patients With Respiratory Failure at Home</brief_title>
  <official_title>Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Societe Francophone de Nutrition Enterale et Parenterale</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association ANTADIR ,</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association AGIR à Dom,</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nutricia France, swizerland),</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Organon</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <brief_summary>
    <textblock>
      Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure
      and nutritional depletion.

      This is a randomized controlled, open clinical trial with two groups.

        -  first group, 100 patients : control group, patients followed with no add-on intervention

        -  Second group, 100 patients : rehabilitation group with education, oral supplements,
           exercise and androgenic steroids.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure
      and nutritional depletion

      State of the art :

      The IRAD2 trial is evaluating a 3-month home intervention which includes education, oral
      supplements, exercise and androgenic steroids in undernourished patients with chronic
      respiratory failure. The main objective is to increase the six-minute walking distance by
      more than 50 m with an improvement in health-related quality-of-life. Secondary end-points
      include a reduction in exacerbation rates by 25%, a reduction in health-related costs and an
      increase in survival during the year following intervention.

      Material and methods :

      This interventional, multi-centre, prospective, two-armed parallel, controlled trial is being
      conducted in 200 patients. In both groups, &quot;Control&quot; and &quot;Rehabilitation&quot;, 7 home visits are
      scheduled during the 3-month intervention for education purpose. In the &quot;Rehabilitation&quot;
      group, patients will receive 160 mg/d of oral testosterone undecanoate in men, 80 mg/d in
      women, oral dietary supplements (563 kcal/d) and exercises on an ergometric bicycle 3 to 5
      times a week.

      Expected results :

      In the event of significant responses to intervention, this trial would validate a
      comprehensive and global home-care for undernourished patients with chronic respiratory
      failure combining therapeutic education, oral supplements, androgenic substitution and
      physical activity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>An increase of the six-minute walking distance by more than 50 m with an improvement in health-related quality-of-life.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in exacerbation rates by 25%</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed by generic QOL.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in health-related costs</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in survival during the year following intervention.</measure>
  </secondary_outcome>
  <enrollment>200</enrollment>
  <condition>Chronic Respiratory Failure</condition>
  <condition>Nutritional Depletion</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>education</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral dietary supplements (563 kcal/d), RESPIFOR</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercises on an ergometric bicycle 3 to 5 times a week</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  well informed and consenting person

          -  woman is old enough to procreate

          -  Assisted respiratory treatment at home for 3 months : oxygenotherapy &gt; 8 hours per day
             and/or assisted ventilation &gt; 6 hours per day.

          -  PaO2 without oxygenotherapy ≤ 8 kPa or 60 mmHg on ambient air at the beginning of
             assisted respiratory treatment.

          -  Affection : chronic obstructive bronchopneumopathy, diffuse bronchial dilatation, non
             neuromuscular restrictive syndrome (pulmonary diffuse infiltration, parietal lesion)
             obstructive and restrictive syndrome.

          -  malnourished person, one of following criteria :Body Mass Index ≤ 21kg/m2 or weight
             loss (10% of the previous weight) or non-fatty mass measured by 50 Hz impedancemetry
             ≤25th percentiles or ≤ 63% of ideal weight for women, ≤ 67% of ideal weight for men.

        Exclusion Criteria:

          -  Sleep apnea with daytime drowsiness (drowsiness scale of Epworth &gt; 9/24)

          -  Known pathology that reduce the vital prognosis at 6 months (AIDS, cancer...).

          -  History of hormone dependent cancer ( breast cancer, prostate cancer), pathologic
             Prostate Specific Antigen.

          -  Inability to follow a rehabilitation program
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe PISON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pneumology Department, University Hospital of Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Dominique Larrey</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Department of Cyr Voisin</name>
      <address>
        <city>Loos</city>
        <zip>59374</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital la Pitiè-Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Bois Guillaume</name>
      <address>
        <city>Rouen</city>
        <zip>76230</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North University Hospital of St Etienne</name>
      <address>
        <city>St Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departement of Medicine, University Hospital of Genève</name>
      <address>
        <city>Genève</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Veale D, Chailleux E, Taytard A, Cardinaud JP. Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines. Eur Respir J. 1998 Oct;12(4):780-4.</citation>
    <PMID>9817145</PMID>
  </reference>
  <reference>
    <citation>Rönning O. Alterations in craniofacial morphogenesis induced by parenterally administered papain. An experimental study on the rat. Suom Hammaslaak Toim. 1971;67:Suppl 3:3-96.</citation>
    <PMID>5292850</PMID>
  </reference>
  <reference>
    <citation>Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest. 1996 Mar;109(3):741-9.</citation>
    <PMID>8617085</PMID>
  </reference>
  <reference>
    <citation>Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981 Mar 28;1(8222):681-6.</citation>
    <PMID>6110912</PMID>
  </reference>
  <reference>
    <citation>Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J. 1996 Nov;9(11):2335-9.</citation>
    <PMID>8947081</PMID>
  </reference>
  <reference>
    <citation>Barnes PJ. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S72-9. Review.</citation>
    <PMID>10556174</PMID>
  </reference>
  <reference>
    <citation>Hunter AM, Carey MA, Larsh HW. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1981 Oct;124(4):376-81.</citation>
    <PMID>6794394</PMID>
  </reference>
  <reference>
    <citation>Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993 May;147(5):1151-6.</citation>
    <PMID>8484624</PMID>
  </reference>
  <reference>
    <citation>Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000 Mar;6(2):110-5. Review.</citation>
    <PMID>10741769</PMID>
  </reference>
  <reference>
    <citation>Schols AM, Mostert R, Soeters PB, Greve LH, Wouters EF. Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax. 1989 Nov;44(11):937-41.</citation>
    <PMID>2595635</PMID>
  </reference>
  <verification_date>July 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2005</study_first_submitted>
  <study_first_submitted_qc>September 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2005</study_first_posted>
  <last_update_submitted>July 7, 2009</last_update_submitted>
  <last_update_submitted_qc>July 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2009</last_update_posted>
  <keyword>Chronic Respiratory Failure</keyword>
  <keyword>Pulmonary Rehabilitation</keyword>
  <keyword>Nutritional Depletion</keyword>
  <keyword>Home</keyword>
  <keyword>COPD</keyword>
  <keyword>Oral Dietary Supplements</keyword>
  <keyword>Therapeutic Education</keyword>
  <keyword>Androgens</keyword>
  <keyword>Exacerbation</keyword>
  <keyword>Survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

